Coronary allograft vasculopathy remains one of the leading causes of death beyond the first
year post transplant. As a result of denervation following transplantation, patients lack …

Coronary allograft vasculopathy fails to give a warning anginal pain due to denervation and
often presents with acute coronary syndrome, ventricular dysfunction, or sudden cardiac …

One of the most important causes for long‐term graft failure in pediatric heart transplant
recipients is coronary allograft vasculopathy (CAV). Graft survival is approximately 50% at 5 …

Cardiomyopathy in children accounts for greater than 50% of the cases of end-stage cardiac
disease leading to heart transplantation in children. While early survival is excellent, late …

Metabolic parameters for coronary allograft vasculopathy (CAV) have not been well defined
in children. CAV (by angiography or autopsy) was studied in 337 heart recipients on a …

Background Heart transplantation has become the standard of care for pediatric patients
with end‐stage heart disease, and outcomes have consistently improved over the last few …

Coronary allograft vasculopathy is the current leading cause for late graft loss following
cardiac transplantation. Its pathogenesis is multifactorial, including immune, constitutional …

The major limitation of long-term survival after cardiac transplantation is allograft
vasculopathy, which consists of concentric and diffuse intimal hyperplasia. The disease still …

Background Coronary allograft vasculopathy (CAV) is the leading cause of death after
pediatric heart transplantation from 1 year postoperation. Anecdotal evidence suggests a …

The single largest cause of late graft loss in pediatric cardiac transplantation is transplant
coronary artery vasculopathy (CAV). The mechanism of CAV remains unknown; it appears to …